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Abstract
Background: A mammary-type myofibroblastoma is a rare soft tumor; extramammary myofibroblastomas are
especially rare.
Case presentation: A 51-year-old woman presented to our department for evaluation of a mass on the right lower
abdominal wall. The mass was then excised completely. Gross examination showed a huge, well-circumscribed soft
tissue mass. The pathologic diagnosis was an extramammary myofibroblastoma. There was no recurrence after
excision at the 6-month follow-up visit.
Conclusions: A mammary-type myofibroblastoma is a benign soft tissue neoplasm. No malignant behavior and/or
recurrence of mammary-type myofibroblastomas after surgical resection have been described as a function of size
and location. The present case aimed to provide a possible differential diagnosis for such abdominal masses.
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Background
Mammary myofibroblastomas are benign tumors, which
were first described in the breast by Wargotz et al. in
1987 [1]. Extramammary myofibroblastomas have been
reported more frequently. Previous reports [2, 3] have
suggested that the inguinal/groin region is the usual site
for extramammary myofibroblastomas. The tumor usu-
ally consists of spindle cells [4] and lacks genetic mater-
ial in the 13q14 region [5]. This is the second case
report of a myofibroblastoma on the abdominal wall.
This study was approved by the hospital’s Ethics
Committee
Case presentation
A 51-year-old female presented to our department (the
Third People’s Hospital of Dalian, Dalian, China) com-
plaining of a mass on the right lower abdominal wall
that had been there for 20 years. The patient had normal
vital signs. The mass on the right lateral abdominal wall
was located through physical examination of the
abdomen. The mass was approximately 2 × 4 cm in
diameter, well-circumscribed, firm, and painless. Labora-
tory testing (blood and biochemistry routine examin-
ation) was normal. Computed tomography (CT; Fig. 1)
revealed thickened muscle of the right lateral abdominal
wall. Thus, surgical excision was recommended. Intra-
operatively, a mass was noted in the right aspect of the
internal oblique muscle of the abdomen with no inva-
sion of the underlying tissues. A complete resection of
the mass was performed. The tumor was well-
circumscribed, firm, and measured approximately 2 ×
3 × 4 cm (Fig. 2). The tumor had a dusty pink color and
resilient characteristics. A frozen section showed a spin-
dle cell tumor, and pathologic evaluation of the tumor
revealed an extramammary myofibroblastoma. Immuno-
histochemistry revealed that the mass was smooth
muscle actin (SMA)-positive, S-100-negative, CD34-
negative, and the Ki67+ <1 %. The patient was followed
for 6 months, and no recurrence was noted.
Discussion
A mammary myofibroblastoma is a benign tumor that
was first described in the breast [1]. Mammary myofi-
broblastomas are well-circumscribed with abundant
fascicular clusters of spindle cells as the main compo-
nent [6]. Extramammary myofibroblastomas are rare.
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McMenamin [5] has reported a case of abdominal wall
myofibroblastoma. Extramammary myofibroblastomas
often originate from the embryonic milk line, similar to
accessory breasts [5]. Extramammary myofibroblastomas
are most often found in the iliac region [3] and rarely in
the retroperitoneum, axilla, posterior vaginal wall, mid-
back, left buttocks, paratesticular region [5], seminal
vesicle [7], and perianal region [8].
Extramammary myofibroblastomas have a predilection
for older men, post-menopausal women, children, and
adolescents [1]. Abdul-Ghafar [2] reported that the aver-
age age of patients with extramammary myofibroblasto-
mas was 52.5 years. The typical symptoms in patients
with extramammary myofibroblastomas include slowly
growing painless tumors; few patients report pain. The
diameter of extramammary myofibroblastoma ranges
from 1 to 4 cm [1, 5].
The tumor is usually well-demarcated, and the color
is white-to-gray. A rubbery consistency with a thin fi-
brous capsule and hemorrhagic areas have also been
described [9].
The histopathologic changes associated with extra-
mammary myofibroblastomas often include abundant
fascicular clusters of spindle- and oval-shaped cells,
which are arranged in interlaced or swirled patterns [4].
The above characteristic was also detected in our
patient.
Ultrasound often demonstrates a solid structure with
mixed echogenicity or lobulated margins in patients with
extramammary myofibroblastomas [10]. CT can also be
performed to exclude the possibility of a different origin
or involvement in proximal structures [3]. In the present
case, CT revealed hyperplastic muscle of the right lateral
abdominal wall, which was not symmetric with the
contralateral side.
Xu et al. [4] indicate that CT and MRI are useful im-
aging methods in the diagnosis of myofibroblastoma.
Shinojima et al. [11] described myofibroblastoma as a
low- or mixed low- and high-density mass on CT, which
was similar with CT of our present patient. Because of
the patient’s reason, MRI was not performed. Shinojima
et al. [11] refer that the myofibroblastoma was isointense
on T1- and hypointense on T2-weighted MI. The ab-
sence of MRI resulted in an imperfect evaluation. There-
fore, when doctors encounter a tumor like this,
examination about that should be carried out as far as
possible, including ultrasound, CT, and MRI, even fine
needle aspiration.
The tumor is usually shown to be positive for
smooth muscle actin, muscle-specific actin, and
vimentin and negative for c-kit, carcinoembryonic
antigen, keratins, S-100, human melanoma black-45
(HMB-45), and Epstein-Barr virus latent membrane
protein 1. Reactivity to factor VIII-related antigen (a
marker of endothelial cells), EMA, MAK-6 (cytokera-
tin; a marker of epithelial cells and meningeal cells),
and glial fibrillary acidic protein is negative [3, 12, 13].
Extramammary myofibroblastomas are weakly positive
for desmin and CD34 [4, 11]. In the present case,
immunohistochemical staining was SMA-positive, S-
100-negative, CD34-negative, and Ki67+ <1 %.
The differential diagnosis of this tumor includes the
following: Kaposi’s sarcoma, leiomyosarcoma, intranodal
schwannoma, benign metastasizing leiomyoma (BML),
follicular dendritic cell sarcoma (FDCS), inflammatory
myofibroblastic tumor (IMT), metastatic malignant mel-
anoma, and metastatic carcinoma [9].
Kaposi’s sarcoma is primarily a borderline vascular
tumor implicating the skin and mucosa, but in more
advanced stages, the lymph nodes and almost any in-
ternal organ could also be involved; human herpes-
virus 8 (HHV8) is considered the causative agent for
Kaposi’s sarcoma [14], while myofibroblastomas usu-
ally spring from the embryonic milk line and locate
at mamma.
Fig. 1 Compared with the left side, thickened muscle was noted on
the right lateral abdominal wall. There was no clear limit of the mass
Fig. 2 A white-to-gray, well-circumscribed, firm mass, approximately
2 × 3 × 4 cm in size
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Leiomyosarcoma is a malignant mesenchymal tumor
with smooth muscle origin that represents 5–7 % of all
soft tissue sarcomas [15], which is different from the
origin of myofibroblastomas. Intranodal schwannoma
means schwannoma arising in lymph nodes, reclassified
as palisaded myofibroblastomas [16, 17].
Intranodal schwannoma were often positive for vimen-
tin and S100, which are similar with myofibroblastomas,
and negative for SMA and CD34, which are not similar
with myofibroblastomas. The findings of intranodal
schwannoma were consistent with a diagnosis of primary
schwannoma of the lymph node [17].
BML is a rare neoplastic process in which of the uter-
ine leiomyomas metastasize to distant sites, the most
common of which are the lungs [18], and the patients
often are treated with hysterectomy [19]. The difference
between BML and myofibroblastomas is their common
location.
Dendritic cell sarcoma (DCS) been previously de-
scribed by many terms such as lymphoma, sarcoma, or
histiocytic neoplasm, reflecting the controversy about
the tumors [20]. FDCS is specifically immunopositive to
CD21, CD35 and/or CD23, vimentin, fascin, HLA-DR,
EMA, D2-40, clusterin, and CXCL13 [21].
IMT is a rare mesenchymal tumor and has been con-
sidered an inflammatory condition; the presentations of
neoplastic proliferation include invasive potential, recur-
rences, and metastases [22]. It is mostly located in the
lungs, then in the abdomen (especially in the mesentery),
and other parts such as the liver, bladder, and stomach.
The clinical presentation depends on its location [23].
Metastatic malignant melanoma and metastatic carcin-
oma could metastasize to any organ or multiple organs.
As typical symptoms are not specific and show organ-
specific outcomes depending on metastasized lesions, it
is difficult to be suspected at the onset [24]. Myofibro-
blastoma have a well-circumscribed degree different
from metastatic malignant melanoma and metastatic
carcinoma.
Conclusions
Extramammary-type myofibroblastomas are benign soft
masses without malignant potential. Surgical resection is
the preferred method for cure, and the recurrence rate is
low. As an extremely rare tumor, physicians should pay
more attention to differential diagnosis.
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